Catalyst Wire Dossier Catalyst Wire Dossier

mRNA-1273 booster vaccine

mRNA-1273 · ModernaTX, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1273 booster vaccine, covering 2024-08-09 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19 [Phase 2, Phase 3]

See pricing